Acesso livre
Acesso livre

Infectologia

Suporte respiratório não invasivo no tratamento da pneumonia aguda por COVID-19: considerações para a prática clínica e prioridades para a pesquisa – “Dois estudos randomizados e controlados indicam superioridade da ventilação não invasiva sobre o oxigênio nasal de alto fluxo na redução da necessidade de intubação.”

22 Nov, 2021 | 09:38h

Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – The Lancet Respiratory Medicine

Conteúdo relacionado: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated with better outcomes.

 

Comentário no Twitter

 

Orientação EuGMS | Tratamento de pacientes com COVID-19 pós-aguda na reabilitação geriátrica.

22 Nov, 2021 | 09:37h

Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance – European Geriatric Medicine

Conteúdos relacionados:

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

Estimativa da taxa de fatalidade da infecção (TFI) por SARS-CoV-2 por idade e status de comorbidade usando o rastreamento de anticorpos em doadores de sangue durante a epidemia de COVID-19 na Dinamarca – “A TFI foi baixa em pessoas com menos de 51 anos sem comorbidade durante as 2 ondas (TFI combinada = 3,36 por 100.000 infecções).”

22 Nov, 2021 | 09:35h

Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – The Journal of Infectious Diseases

 

Comentário no Twitter

 

M-A | Plasma convalescente não reduz a mortalidade na COVID-19.

22 Nov, 2021 | 09:34h

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials – BMC Infectious Diseases

Conteúdos relacionados:

RCT: Another study shows convalescent plasma does not improve outcomes in critically ill patients with Covid-19.

RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with COVID-19.

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.

M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.

RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.

Delta é a última “supervariante” da Covid?

22 Nov, 2021 | 09:32h

Is Delta the last Covid ‘super variant’? – The Guardian

Não, pessoas vacinadas não são “tão infecciosas” quanto pessoas não vacinadas caso venham a ter COVID.

22 Nov, 2021 | 09:31h

No, vaccinated people are not ‘just as infectious’ as unvaccinated people if they get COVID – The Conversation

[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”

22 Nov, 2021 | 09:23h

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Conteúdos relacionados:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

Estudo RECOVERY | Aspirina como terapia complementar não reduziu a mortalidade em pacientes internados com COVID-19.

19 Nov, 2021 | 13:20h

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Comentário convidado: Studying the coagulopathy of COVID-19 – The Lancet

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Revisitando as políticas de COVID-19: 10 recomendações baseadas em evidências para seguir daqui em diante.

19 Nov, 2021 | 13:19h

Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here – BMC Public Health

Editorial | Vacinas contra COVID-19 para crianças – “Embora seja verdade que a maioria das crianças tenham doença assintomática ou leve, algumas ficarão bastante doentes e um pequeno número irá a óbito. Este é o motivo de crianças serem vacinadas contra gripe, meningite, catapora e hepatite.”

19 Nov, 2021 | 13:17h

COVID-19 vaccines for children – Science

Conteúdo relacionado: Review: Should children under 12 years of age be vaccinated against COVID-19?

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.